Publication | Closed Access

Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia: the JALSG-ALL97 study

Hematological MalignancyMedicineMixed-phenotype Acute LeukemiaDose-escalated DoxorubicinHematologyAcute Lymphoblastic LeukemiaIntensified Consolidation TherapyPharmacotherapyAdult T-cell Leukemia-lymphomaOncologyRadiation OncologyChemotherapyHealth Sciences